Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19
Clinical trial NCT05633433 · UNKNOWN
Trial details
- NCT number
- NCT05633433
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2024-06-15
- Enrollment
- 1550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.